Table 1 Basic demographics
Group ropivacaine | Group placebo | |
|---|---|---|
No patients | 47 | 53 |
Gender, M | 23 | 25 |
Age, years | 69 (11) | 69 (8) |
Height, cm | 170 (10) | 171 (10) |
Weight, kg | 79 (18) | 78 (14) |
ASA | ||
1 | 16 | 24 |
2 | 27 | 28 |
3 | 4 | 1 |
Duration of surgery, min | 62 (16) | 61 (17) |
Duration from end of surgery to block, min | 63 (28) | 65 (28) |